Unknown

Dataset Information

0

Small Molecules Restore Bestrophin 1 Expression and Function of Both Dominant and Recessive Bestrophinopathies in Patient-Derived Retinal Pigment Epithelium.


ABSTRACT: Purpose:Bestrophinopathies are a group of untreatable inherited retinal dystrophies caused by mutations in the retinal pigment epithelium (RPE) Cl- channel bestrophin 1. We tested whether sodium phenylbutyrate (4PBA) could rescue the function of mutant bestrophin 1 associated with autosomal dominant and recessive disease. We then sought analogues of 4PBA with increased potency and determined the mode of action for 4PBA and a lead compound 2-naphthoxyacetic acid (2-NOAA). Lastly, we tested if 4PBA and 2-NOAA could functionally rescue bestrophin 1 function in RPE generated from induced pluripotent stem cells (iPSC-RPEs) derived from patients with a dominant or recessive bestrophinopathy. Methods:Global and plasma membrane expression was determined by Western blot and immunofluorescent microscopy, respectively. The effect of 4PBA and 2-NOAA on transcription was measured by quantitative RT-PCR and the rate of protein turnover by cycloheximide chase and Western blot. Channel function was measured by whole-cell patch clamp. Results:4PBA and 2-NOAA can rescue the global and membrane expression of mutant bestrophin 1 associated with autosomal dominant disease (Best vitelliform macular dystrophy [BVMD]) and autosome recessive bestrophinopathy (ARB), and these small molecules have different modes of action. Both 4PBA and 2-NOAA significantly increased the channel function of mutant BVMD and ARB bestrophin 1 in HEK293T and iPSC-RPE cells derived from patients with BVMD and ARB. For 4PBA, the increased mutant channel function in BVMD and ARB iPSC-RPE was equal to that of wild-type iPSC-RPE bestrophin 1. Conclusions:The restoration of bestrophin 1 function in patient-derived RPE confirms the US Food and Drug Administration-approved drug 4PBA as a promising therapeutic treatment for bestrophinopathies.

SUBMITTER: Liu J 

PROVIDER: S-EPMC7405785 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Small Molecules Restore Bestrophin 1 Expression and Function of Both Dominant and Recessive Bestrophinopathies in Patient-Derived Retinal Pigment Epithelium.

Liu Jingshu J   Taylor Rachel L RL   Baines Richard A RA   Swanton Lisa L   Freeman Sally S   Corneo Barbara B   Patel Achchhe A   Marmorstein Alan A   Knudsen Travis T   Black Graeme C GC   Manson Forbes F  

Investigative ophthalmology & visual science 20200501 5


<h4>Purpose</h4>Bestrophinopathies are a group of untreatable inherited retinal dystrophies caused by mutations in the retinal pigment epithelium (RPE) Cl- channel bestrophin 1. We tested whether sodium phenylbutyrate (4PBA) could rescue the function of mutant bestrophin 1 associated with autosomal dominant and recessive disease. We then sought analogues of 4PBA with increased potency and determined the mode of action for 4PBA and a lead compound 2-naphthoxyacetic acid (2-NOAA). Lastly, we teste  ...[more]

Similar Datasets

| S-EPMC2820107 | biostudies-literature
| S-EPMC2775838 | biostudies-literature
| S-EPMC4443363 | biostudies-literature
| S-EPMC4390793 | biostudies-literature
| S-EPMC5688231 | biostudies-literature
| S-EPMC2265653 | biostudies-literature
| S-EPMC2493379 | biostudies-literature
| S-EPMC6397318 | biostudies-literature
| S-EPMC8922333 | biostudies-literature
| S-EPMC7794276 | biostudies-literature